CG FV Pill - yellow round, 7mm
Generic Name: letrozole
Pill with imprint CG FV is Yellow, Round and has been identified as Femara 2.5 mg. It is supplied by Novartis Pharmaceuticals.
Femara is used in the treatment of Breast Cancer, Adjuvant; Breast Cancer, Metastatic; Breast Cancer and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Femara 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for CG FV
Femara
- Generic Name
- letrozole
- Imprint
- CG FV
- Strength
- 2.5 mg
- Color
- Yellow
- Size
- 7.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Aromatase inhibitors, Hormones/antineoplastics
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novartis Pharmaceuticals
- Inactive Ingredients
-
silicon dioxide,
ferric oxide yellow,
hypromelloses,
lactose monohydrate,
magnesium stearate,
corn starch,
microcrystalline cellulose,
polyethylene glycol,
sodium starch glycolate type A potato,
magnesium silicate,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00078-0249 | Novartis Pharmaceuticals Corporation |
| 54868-4151 (Discontinued) | Physicians Total Care Inc. (repackager) |
| 54569-5714 | A-S Medication Solutions, LLC (repackager) |
| 35356-0409 | Lake Erie Medical and Surgical Supply (repackager) |
More about Femara (letrozole)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (67)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Generic availability
- Support group
- Drug class: aromatase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
